Claris Lifesciences (Delisted) share news and announcements

BSE: 533288

Last traded ₹396.55 on 14 Mar 2018

Delisted on 22 Mar 2018.

Claris Lifesciences share news and announcements

337 announcements, routine notices left out, newest first. Page 3 of 7.

Aug 2016
- 27 Aug · Claris receives AND A approval for Flumazenil Injection after PAI Inspection
  Press Release dated August 27, 2016, titled "Claris receives ANDA approval for Flumazenil Injection after PAI Inspection". (opens in a new tab)
- 26 Aug · Claris update on the PAI US FDA inspection
  Press Release dated August 26, 2016 titled 'Claris update on the PAI US FDA inspection' (opens in a new tab)
- 19 Aug · Board meeting
  Board of Directors of the Company at its meeting held on August 19, 2016, has considered, approved and taken on record the following: .... (opens in a new tab)
- 19 Aug · Results
  1. Standalone Financial Results for the period ended June 30, 2016 2. Consolidated Financial Results for the period ended June 30, 2016 .... (opens in a new tab)
- 12 Aug · Board meeting
  Pursuant to the SEBI Circular No. CIR/CFD/FAC/62/2016 dated July 5, 2016, the SEBI has extended time line for submitting the financial .... (opens in a new tab)
- 11 Aug · Legal
  Clarification on news item floating in the media. (opens in a new tab)
Jul 2016
- 30 Jul · Meeting
  The 21st Annual General Meeting (AGM) of the Company was held on July 29, 2016. (opens in a new tab)
- 30 Jul · Results
  Details of Voting results at the 21st Annual General Meeting (AGM) of the Company held on July 29, 2016, under Regulation 44(3) of .... (opens in a new tab)
- 30 Jul · Disclosure
  Abellon Energy Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 29 Jul · Disclosure
  Abellon Energy Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 29 Jul · Meeting
  Twenty First Annual General Meeting ("AGM") of the Members of the Company concluded July 29, 2016 at J. B. Auditorium, Ahmedabad Management .... (opens in a new tab)
- 28 Jul · Disclosure
  IDBI Trusteeship Services Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 26 Jul · Claris receives ANDA approval for Bupivacaine Injection
  Press Release dated July 26, 2016 titled "Claris receives ANDA approval for Bupivacaine Injection". (opens in a new tab)
- 14 Jul · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) .... (opens in a new tab)
- 13 Jul · Shareholding for the Period Ended June 30, 2016
  Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click ....
- 6 Jul · Claris receives ANDA approval for Tobramycin Injection
  Press Release dated July 06, 2016 titled "Claris receives ANDA approval for Tobramycin Injection". (opens in a new tab)
- 5 Jul · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from July 23, 2016 to July 29, 2016 (both days inclusive) .... (opens in a new tab)
Jun 2016
- 16 Jun · Rating
  The 'India Rating & Research (Ind-Ra)' has affirmed Claris Lifesciences Limited ("CLL") Long Term Rating at 'IND A' with a "Stable" outlook. (opens in a new tab)
- 13 Jun · Disclosure
  Athanas Enterprises Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 2 Jun · Declaration regarding Audit Report with unmodified opinion
  Declaration regarding Audit Report with unmodified opinion. (opens in a new tab)
May 2016
- 30 May · Claris announces receipt of EIR from the US FDA
  Press Release dated May 30, 2016 titled "Claris announces receipt of EIR from the US FDA". (opens in a new tab)
- 6 May · Results
  Q4 FY16 - Results Updates (opens in a new tab)
- 6 May · Results
  1. Standalone Financial Results for the period ended March 31, 2016 2. Consolidated Financial Results for the period ended .... (opens in a new tab)
- 6 May · Dividend
  Board of Directors of the Company at its meeting held on May 06, 2016 which commenced at 11.00 AM and concluded at 5:30 PM, inter alia, ....
- 3 May · Board meeting
  Meeting of the Board of Directors of the Company will be held on May 06, 2016, inter alia, to recommend final dividend, if any, for the financial ....
Apr 2016
- 18 Apr · Shareholding for the Period Ended March 31, 2016
  Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click ....
- 13 Apr · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) .... (opens in a new tab)
Mar 2016
- 25 Mar · Results
  Details of Voting results at the Postal Ballot of the Company held on March 25, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (opens in a new tab)
Feb 2016
- 24 Feb · Meeting
  Advertisement of postal ballot notice published on February 24, 2016, in newspapers. (opens in a new tab)
- 23 Feb · Meeting
  Notice of Postal Ballot. (opens in a new tab)
- 7 Feb · Shareholding for the Period Ended December 31, 2015
  Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click ....
- 5 Feb · Board meeting
  Board of Directors of the Company at its meeting held on February 05, 2016, inter alia, has also proposed to seek approval of the Shareholders ....
- 5 Feb · Results
  1. Financial Results for the period ended December 31, 2015 (Standalone and Consolidated). 2. Limited Review Report for the .... (opens in a new tab)
Jan 2016
- 16 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation .... (opens in a new tab)
- 1 Jan · Results
  Updated Financial Results for the period ended September 30, 2015. (opens in a new tab)
Dec 2015
- 26 Dec · Updates
  Claris Lifesciences Limited (CLL), has been allotted 4,840,000 numbers of 0.1% Non Cumulative Redeemable Preference Shares of Rs. ....
- 24 Dec · Authorised KMPs to determine materiality of events/information
  Authorised Key Managerial Personnel to determine materiality of events/information (opens in a new tab)
Nov 2015
Oct 2015
- 22 Oct · Meeting
  Proceedings of the 20th Annual General Meeting (AGM) of the Company held on September 23, 2015. (opens in a new tab)
- 10 Oct · Shareholding Pattern For September 30, 2015
  Shareholding Pattern as on September 30, 2015. (opens in a new tab)
Sep 2015
Aug 2015
- 31 Aug · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from September 19, 2015 to September 23, 2015 (both days inclusive) .... (opens in a new tab)
- 13 Aug · Results
  Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended June 30, 2015. (opens in a new tab)
- 12 Aug · Claris receives Prior Approval Supplement for Furosemide Injection in US
  Press Release dated August 12, 2015 titled "Claris receives Prior Approval Supplement for Furosemide Injection in US." (opens in a new tab)
- 10 Aug · Business
  Press Release being issued with regard to Income Tax Authorities - Search / Survey". (opens in a new tab)